Bromonordiazepam is the active metabolite of of the Soviet developed Gidazepam. Bromonordiazepam is closely related is to Diazepam in structure, has a very long half life and is exceptionally anxiolytic with limited non-therapeutic potential.
7-Bromo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one inhibits HIV-1 reverse transcription.
Desalkylgidazepam is an analytical reference standard categorized as a benzodiazepine metabolite.
Desalkylgidazepam is a metabolite of gidazepam. This product is intended for research and forensic applications.